These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32083300)

  • 21. LINC00673 rs11655237 C>T and susceptibility to Wilms tumor: A five-center case-control study.
    Li S; Lin A; Han D; Zhou H; Cheng J; Zhang J; Fu W; Zhuo Z; He J
    J Gene Med; 2019 Dec; 21(12):e3133. PubMed ID: 31657076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of association between LINC00673 rs11655237 C>T and Wilms tumor susceptibility.
    Gao X; Jia W; Zhu J; Fu W; Zhu S; Xia H; He J; Liu G
    J Clin Lab Anal; 2019 Sep; 33(7):e22930. PubMed ID: 31257678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMGA2 gene polymorphisms and Wilms tumor susceptibility in Chinese children: a four-center case-control study.
    Cheng J; Zhuo Z; Yang L; Zhao P; Zhang J; Zhou H; He J; Li P
    Biotechnol Appl Biochem; 2020 Nov; 67(6):939-945. PubMed ID: 31746066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
    Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB
    Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
    Huang X; Wu F; Zhang Z; Shao Z
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
    [No Abstract]   [Full Text] [Related]  

  • 26. METTL3 polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study.
    Lin A; Zhou M; Hua RX; Zhang J; Zhou H; Li S; Cheng J; Xia H; Fu W; He J
    J Gene Med; 2020 Nov; 22(11):e3255. PubMed ID: 32716082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of FTO gene polymorphisms in Wilms tumor predisposition: A five-center case-control study.
    Hua RX; Fu W; Lin A; Zhou H; Cheng J; Zhang J; Li S; Liu G; Xia H; Zhuo Z; He J
    J Gene Med; 2021 Aug; 23(8):e3348. PubMed ID: 33894035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The
    He J; Wang F; Zhu J; Zhang Z; Zou Y; Zhang R; Yang T; Xia H
    Aging (Albany NY); 2017 Mar; 9(3):852-859. PubMed ID: 28275206
    [No Abstract]   [Full Text] [Related]  

  • 29. TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.
    Maschietto M; Williams RD; Chagtai T; Popov SD; Sebire NJ; Vujanic G; Perlman E; Anderson JR; Grundy P; Dome JS; Pritchard-Jones K
    PLoS One; 2014; 9(10):e109924. PubMed ID: 25313908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of Pri-miRNA-34b/c and TP53 Polymorphisms on the Risk of Osteoporosis.
    Jia F; Sun R; Li J; Li Q; Chen G; Fu W
    Genet Test Mol Biomarkers; 2016 Jul; 20(7):398-401. PubMed ID: 27227383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
    Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
    Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis.
    Sun Z; Gao W; Cui JT
    BMC Oral Health; 2018 Aug; 18(1):143. PubMed ID: 30126398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LIN28A gene polymorphisms confer Wilms tumour susceptibility: A four-centre case-control study.
    Zhuo Z; Fu W; Liu J; Cheng J; Zhou H; Zhang J; Zhu JH; Xia H; Liu G; He J
    J Cell Mol Med; 2019 Oct; 23(10):7105-7110. PubMed ID: 31338973
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Gao Y; Su YP; Li XL; Lei SJ; Chen HF; Cui SY; Zhang SF; Zou JM; Liu QJ; Sun QF
    Int J Radiat Biol; 2022; 98(7):1235-1242. PubMed ID: 34995174
    [No Abstract]   [Full Text] [Related]  

  • 36. TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
    Cost NG; Mitui M; Khokhar S; Wickiser JE; Baker LA; Rakheja D
    Pediatr Blood Cancer; 2012 Aug; 59(2):326-8. PubMed ID: 22052810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALKBH5 gene polymorphisms and Wilms tumor risk in Chinese children: A five-center case-control study.
    Hua RX; Liu J; Fu W; Zhu J; Zhang J; Cheng J; Li S; Zhou H; Xia H; He J; Zhuo Z
    J Clin Lab Anal; 2020 Jun; 34(6):e23251. PubMed ID: 32091154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Base Excision Repair Gene Polymorphisms and Wilms Tumor Susceptibility.
    Zhu J; Jia W; Wu C; Fu W; Xia H; Liu G; He J
    EBioMedicine; 2018 Jul; 33():88-93. PubMed ID: 29937070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors.
    Rakheja D; Khokhar S; Mitui M; Cost NG
    Pediatr Dev Pathol; 2012; 15(4):286-92. PubMed ID: 22483234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the
    Yang T; Wen Y; Li J; Yang J; Tan T; Pan J; Hu C; Zhang J; Xin Y; Li S; Xia H; He J; Zou Y
    J Cancer; 2019; 10(15):3444-3449. PubMed ID: 31293648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.